Bio Protocol vs TAC Protocol — how do they compare? Bio Protocol trades at Rp441.13 (market cap Rp999,88M, Rp161,38M 24h volume), while TAC Protocol trades at Rp47.8 (market cap Rp223,94M, Rp24,98M 24h volume). The key difference: Bio Protocol is far larger — about 4.5× TAC Protocol's market cap, and Bio Protocol's supply is capped (2,3B / 3,3B BIO (69%)) while TAC Protocol's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and TAC Protocol for 5 Days on average.
| BIO | TAC | |
|---|---|---|
Market Cap | Rp999,88M | Rp223,94M |
Volume (24h) | Rp161,38M | Rp24,98M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 4,7B TAC |
Typical Hold Time | 18 Days | 5 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
TAC Protocol is trading at Rp47,775 with a market cap of Rp224.55 million, showing bearish technical signals despite oversold RSI conditions. The token faces selling pressure with moving averages indicating sustained downward momentum, while oscillators show some buying interest. With a 5-day average hold time suggesting short-term trading activity, the token trades near key support at Rp47 with resistance at Rp50.
Overall outlook remains cautious with technical weakness prevailing. Key opportunities include potential oversold bounce from support levels, while major risks involve continued selling pressure and limited liquidity. Investors should monitor for protocol updates and exchange volume improvements to gauge sustainability of any recovery.
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →TAC is the first EVM-compatible blockchain built specifically for the TON ecosystem and Telegram. It delivers full DeFi functionality from day one with EVM infrastructure, pre-deployed blue-chip DeFi apps, and liquidity from Ethereum and BTC.
Read more on TAC →